Plus Therapeutics (PSTV) EBITDA Margin Growth (5y) (2016 - 2024)
Plus Therapeutics (PSTV) EBITDA Margin Growth (5y) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Plus Therapeutics |
34.26 Mn |
19.15 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
27,127.00 |
| Dec 31, 2023 |
-13,912.00 |
| Sep 30, 2023 |
20,409.00 |
| Jun 30, 2023 |
45,418.00 |
| Mar 31, 2023 |
-30,281.00 |
| Dec 31, 2022 |
-376,822.00 |
| Sep 30, 2022 |
-595,217.00 |
| Mar 31, 2019 |
54,558.00 |
| Dec 31, 2018 |
20,161.00 |
| Sep 30, 2018 |
5,408.00 |
| Jun 30, 2018 |
-31,189.00 |
| Mar 31, 2018 |
-8,289.00 |
| Dec 31, 2017 |
-52,279.00 |
| Sep 30, 2017 |
-16,990.00 |
| Jun 30, 2017 |
-22,092.00 |
| Mar 31, 2017 |
-65,699.00 |
| Dec 31, 2016 |
-805.00 |
| Sep 30, 2016 |
-36,200.00 |
| Jun 30, 2016 |
-39,904.00 |
| Mar 31, 2016 |
40,627.00 |
